Skip to content

Test to confirm the effects of consuming the test food for three months

Test to confirm the effects of consuming the test food for three months - Test to confirm the effects of consuming the test food for three months

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060352
Enrollment
120
Registered
2026-01-29
Start date
2026-01-29
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Daily intake of test food A once a day for 12 consecutive weeks Daily intake of test food B once a day for 12 consecutive weeks Daily intake of test food C once a day for 12 consecutive weeks Non-inte

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 20 to 65 years of age (2) Subjects whose lunch consists only of the test food and who have no difficulty consuming the entire portion (3) Subjects who fully understand the purpose and content of this study and voluntarily agree to participate in the study

Exclusion criteria

Exclusion criteria: Subjects (1)whose blood pressure in the examination room during screening is at or above the level classified as high blood pressure (2)who do not have the habit of eating lunch or whose eating habits are extremely irregular (3)who cannot stop consuming foods and beverages related to the study from the time of the screening (4)with a medical history of diseases requiring dietary and exercise therapy under a doctor's supervision (5)who regularly take health supplements and cannot stop taking them during the study period (6)who regularly use pharmaceutical drugs or quasi-drugs and cannot restrict their intake during the research period (7)currently receiving medical treatment for gastrointestinal diseases that could affect the research, or those with a history of gastrointestinal surgery (8)suspected of having, currently being treated for, or with a history of disorders related to bowel movements, sleep, stress, or fatigue (9)who have shown abnormalities in clinical test values or cardiopulmonary function and are deemed unsuitable for participation in the study (10)who may be at risk of developing allergies in relation to the research (11)who require regular medication, those currently undergoing treatment for a disease, and those with a history of severe diseases that required medication treatment (12)who work in shifts, night shifts, or have irregular daily schedules (13)Heavy drinkers and smoker (14)who have participated in other clinical studies from within one month before the date of consent until four weeks after the end of the trial (15)who plan to become pregnant or breastfeed during the study period (16)expected to experience significant changes in their living environment during the research period (17)whose blood donation volume before the start of the study exceeds the regulations (18)who are aware of imbalances in nutritional intake (19)deemed inappropriate as subjects by the responsible investigator (20)using implanted medical electrical devices

Design outcomes

Primary

MeasureTime frame
Body fat percentage, waist circumference, abdominal visceral fat area, gut short-chain fatty acids, gut putrefactive products, gut microbiota, physical measurements, physiological tests, clinical tests, nutrient intake (sodium, potassium, etc.)

Secondary

MeasureTime frame
IPAQ short, OSA-MA, STAI, brief job stress questionnaire, POMS2, VAS, Chalder fatigue scale, MAIA, water intake, bowel movements

Countries

Japan

Contacts

Public ContactShingo Yamamichi

EP Mediate Co., Ltd. Development Department Trial Planning Section

yamamichi.shingo578@eps.co.jp090-4821-1099

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026